Role of Circulating Microparticles in Impairing Endothelial Function and Activating Oxidative Stress Is Related to No‐Reflow in STEMI
Cardiovascular Therapeutics · 2026
DOI: 10.1155/cdr/9055462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Wen-Bo Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Oxidative Stress, Cell-Derived Microparticles, ST Elevation Myocardial Infarction, Vasodilation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shaanxi Provincial People's Hospital.
Abstract (Originalsprache)
Objective
Patients with ST‐segment elevation myocardial infarction (STEMI) frequently experience no‐reflow (NRF) during percutaneous coronary intervention (PCI). Nevertheless, the pathogenesis of NRF involves multiple factors and has not been fully elucidated to date. Given that endothelial dysfunction, inflammation, and oxidative stress are jointly implicated in both MP‐related processes and NRF occurrence, this study was performed to explore the potential role of circulating microparticles (MPs) in the development of NRF.
Methods
MPs were isolated from healthy subjects ( n = 30), patients with angina and negative coronary angiography (control, n = 30), and STEMI patients with ( n = 30) or without NRF ( n = 30). The effects of MPs on endothelium‐dependent vasodilatation, the expression of caveolin‐1 and endothelial nitric oxide synthase (eNOS), and the production of nitric oxide (NO), superoxide anion (O 2 •− ), and intercellular adhesion molecule 1 (ICAM‐1) were detected in mice. Furthermore, we examined the effects of MPs on the proliferation and endothelial tube formation of human coronary artery endothelial cells (HCAECs), with or without N G ‐nitro‐L‐arginine methyl ester (L‐NAME) preincubation.
Results
Compared with controls and healthy subjects, circulating MP levels were significantly higher in STEMI patients and were further elevated in STEMI patients with NRF. MPs isolated from NRF patients impaired endothelial‐dependent vasodilatation, decreased the expression of phosphorylated eNOS at Ser1177, reduced NO production, HCAECs proliferation, and endothelial tube formation, but upregulated the expression of caveolin‐1 and phosphorylated eNOS at Thr495, and increased the generation of O 2 •− and ICAM‐1. The effects of MPs on HCAECs were partially blocked by L‐NAME.
Conclusions
Circulating MPs are associated with NRF in the clinical context and induce endothelial dysfunction in experimental models. Our findings provide new insight into the underlying molecular mechanisms of NRF in STEMI in experimental models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China.
- Department of Cardiology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China, xjtu.edu.cn.
ORCID-Profile: Wen-Bo Li, Wei Zhang, Feng-Jun Chang, Zhe Li, Yu-Juan Yang, Gong Cheng, Xin Jiang
Förderung
- Shaanxi Provincial People's Hospital
Zitieren
APA
Li, W. B., Zhang, W., Chang, F. J., Li, Z., Yang, Y. J., Cheng, G., & Jiang, X. (2026). Role of Circulating Microparticles in Impairing Endothelial Function and Activating Oxidative Stress Is Related to No‐Reflow in STEMI. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/9055462
Vancouver
Li WB, Zhang W, Chang FJ, Li Z, Yang YJ, Cheng G, et al. Role of Circulating Microparticles in Impairing Endothelial Function and Activating Oxidative Stress Is Related to No‐Reflow in STEMI. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/9055462
BibTeX
@article{Li2026,
author = {Li, Wen-Bo and Zhang, Wei and Chang, Feng-Jun and Li, Zhe and Yang, Yu-Juan and Cheng, Gong and Jiang, Xin},
title = {Role of Circulating Microparticles in Impairing Endothelial Function and Activating Oxidative Stress Is Related to No‐Reflow in STEMI},
journal = {Cardiovascular Therapeutics},
year = {2026},
doi = {10.1155/cdr/9055462}
}
EUVIMED